The tally, one vote per house
27 of 28 research houses agree, +3 houses in 30 days. See which houses, free →
Europe's defence spending build-up covers rising defence budgets and NATO commitments, which researchers expect to lift demand for military equipment and the industrial firms that supply it. The main argument is that the EU's SAFE defence plan and NATO's higher spending targets create a long-term investment cycle, with one house arguing that Germany's defence industry is already boosting manufacturing growth. One house takes a mixed view, noting that some defence stocks have yet to clear key technical resistance levels.
Each house counts once: its newest view on the theme in the last 60 days. The counts are computed, not written by AI; the summary is AI-written from the houses’ views, without names.
Who the houses are
- Banks19
- Asset managers4
- Independent research firms3
- Podcasts2
Types only: names are shown to members. See who said what, free →
Houses discussing it, 12 weeks
Houses with a view in the 60 days to each week’s end. Latest: 28 houses on 3 Nov.
What the theme implies
- European Equities higher
Named in research
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Questions
What is the “Defence spending” theme?
Rising European defence budgets and NATO deterrence commitments lift spending on military equipment and the industrial firms that supply it. It is one of 70 themes FinChiefs counts across published research from banks, asset managers, independent research firms and podcasts.
How many research houses agree?
27 of 28 research houses agree (96%), counting each house's newest view in the last 60 days: 27 agree, 1 is mixed and 0 disagree. That is +3 houses in 30 days. Members see each house by name.
Which instruments do research houses name for this theme?
No fund, ETF or index has been named by at least 2 research houses for this theme yet.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.